Zelluna ASA (OSL:ZLNA)
Norway · Delayed Price · Currency is NOK 21.10
-1.20 (-5.38%)
Aug 24, 2026, 4:26 PM CET
Zelluna ASA Revenue
Revenue (ttm)
8.00K
Revenue Growth
-84.91%
P/S Ratio
77,578.79
Revenue / Employee
533.33
Employees
15
Market Cap
620.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 53.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 13.30M | 175.00K | 1.33% |
| Dec 31, 2021 | 13.13M | 704.38K | 5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 133.41M |
| Arctic Bioscience AS | 42.62M |
| Oncoinvent ASA | 28.07M |
| SoftOx Solutions AS | 16.27M |
| Aqua Bio Technology ASA | 7.53M |
| Nykode Therapeutics AS | 5.42M |
| Thor Medical ASA | 839.00K |
| Lytix Biopharma ASA | 377.00K |
Zelluna ASA News
- 4 days ago - Zelluna ASA Earnings Call Transcript: Q2 2026 - Transcripts
- 4 days ago - Zelluna ASA Quarterly report: Q2 2026 - Filings
- 4 days ago - Zelluna ASA Slides: Q2 2026 - Filings
- 6 days ago - Zelluna Advances Phase 1 ZIMA-101 Trial Following Positive Safety Review From Independent Committee - Nasdaq
- 3 months ago - Zelluna ASA Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Zelluna ASA Quarterly report: Q1 2026 - Filings
- 3 months ago - Zelluna ASA Slides: Q1 2026 - Filings
- 4 months ago - Zelluna ASA Transcript: Capital Markets Update 2026 - Transcripts